Dr. Goldberg on Sequencing Following Treatment With Osimertinib in NSCLC OncLive 2:00 6 years ago 235 Далее Скачать
Dr. Goldberg on Options After Developing Resistance to Osimertinib for NSCLC OncLive 1:16 6 years ago 1 499 Далее Скачать
Dr. Oxnard on Detecting Resistance Mechanisms After Treatment With Osimertinib OncLive 1:31 7 years ago 773 Далее Скачать
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC Future Science Group 6:28 6 years ago 2 005 Далее Скачать
Case 4: Treating EGFR+ NSCLC After Osimertinib Targeted Oncology 6:55 6 years ago 3 013 Далее Скачать
Osimertinib for EGFR T790M Resistance Mutations in NSCLC OncLive 3:59 7 years ago 1 210 Далее Скачать
EGFR-Mutant NSCLC: Selecting Patients for Osimertinib Targeted Oncology 3:27 6 years ago 51 Далее Скачать
Copy of Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 0:40 6 years ago 39 Далее Скачать
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC OncLive 2:02 6 years ago 138 Далее Скачать
Treatment After Progression on Osimertinib for EGFR+ NSCLC Targeted Oncology 2:59 4 years ago 1 308 Далее Скачать
Dr. Wakelee on Benefits of Osimertinib in EGFR-Mutant NSCLC Treatment OncLive 1:57 5 years ago 562 Далее Скачать
